DORMAN PRODUCTS INC (DORM) Fundamental Analysis & Valuation

NASDAQ:DORM • US2582781009

Current stock price

104.56 USD
-1.91 (-1.79%)
At close:
104.56 USD
0 (0%)
After Hours:

This DORM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. DORM Profitability Analysis

1.1 Basic Checks

  • In the past year DORM was profitable.
  • DORM had a positive operating cash flow in the past year.
  • DORM had positive earnings in each of the past 5 years.
  • DORM had a positive operating cash flow in each of the past 5 years.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 8.19%, DORM belongs to the top of the industry, outperforming 87.80% of the companies in the same industry.
  • DORM's Return On Equity of 13.82% is amongst the best of the industry. DORM outperforms 87.80% of its industry peers.
  • The Return On Invested Capital of DORM (13.20%) is better than 90.24% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for DORM is above the industry average of 9.26%.
  • The 3 year average ROIC (11.36%) for DORM is below the current ROIC(13.20%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.19%
ROE 13.82%
ROIC 13.2%
ROA(3y)7.22%
ROA(5y)6.94%
ROE(3y)13.19%
ROE(5y)13.07%
ROIC(3y)11.36%
ROIC(5y)10.19%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 9.59%, DORM belongs to the top of the industry, outperforming 92.68% of the companies in the same industry.
  • In the last couple of years the Profit Margin of DORM has remained more or less at the same level.
  • DORM has a Operating Margin of 16.72%. This is amongst the best in the industry. DORM outperforms 97.56% of its industry peers.
  • DORM's Operating Margin has improved in the last couple of years.
  • DORM has a better Gross Margin (42.14%) than 90.24% of its industry peers.
  • In the last couple of years the Gross Margin of DORM has grown nicely.
Industry RankSector Rank
OM 16.72%
PM (TTM) 9.59%
GM 42.14%
OM growth 3Y19.24%
OM growth 5Y6.5%
PM growth 3Y11%
PM growth 5Y-0.41%
GM growth 3Y8.98%
GM growth 5Y3.75%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. DORM Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DORM is creating some value.
  • Compared to 1 year ago, DORM has less shares outstanding
  • Compared to 5 years ago, DORM has less shares outstanding
  • DORM has a better debt/assets ratio than last year.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • DORM has an Altman-Z score of 4.47. This indicates that DORM is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 4.47, DORM belongs to the best of the industry, outperforming 82.93% of the companies in the same industry.
  • DORM has a debt to FCF ratio of 5.81. This is a neutral value as DORM would need 5.81 years to pay back of all of its debts.
  • DORM has a better Debt to FCF ratio (5.81) than 60.98% of its industry peers.
  • DORM has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.27, DORM is in the better half of the industry, outperforming 63.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 5.81
Altman-Z 4.47
ROIC/WACC1.4
WACC9.45%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.3 Liquidity

  • A Current Ratio of 3.09 indicates that DORM has no problem at all paying its short term obligations.
  • DORM has a Current ratio of 3.09. This is in the better half of the industry: DORM outperforms 75.61% of its industry peers.
  • DORM has a Quick Ratio of 1.14. This is a normal value and indicates that DORM is financially healthy and should not expect problems in meeting its short term obligations.
  • DORM has a Quick ratio (1.14) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.09
Quick Ratio 1.14
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. DORM Growth Analysis

3.1 Past

  • DORM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.23%, which is quite impressive.
  • The Earnings Per Share has been growing by 20.72% on average over the past years. This is a very strong growth
  • DORM shows a small growth in Revenue. In the last year, the Revenue has grown by 6.03%.
  • The Revenue has been growing by 14.28% on average over the past years. This is quite good.
EPS 1Y (TTM)24.23%
EPS 3Y23.06%
EPS 5Y20.72%
EPS Q2Q%-1.36%
Revenue 1Y (TTM)6.03%
Revenue growth 3Y7.11%
Revenue growth 5Y14.28%
Sales Q2Q%0.78%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.46% on average over the next years.
  • Based on estimates for the next years, DORM will show a small growth in Revenue. The Revenue will grow by 5.64% on average per year.
EPS Next Y0.95%
EPS Next 2Y5.42%
EPS Next 3Y-0.14%
EPS Next 5Y6.46%
Revenue Next Year5.75%
Revenue Next 2Y5.33%
Revenue Next 3Y6%
Revenue Next 5Y5.64%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. DORM Valuation Analysis

4.1 Price/Earnings Ratio

  • DORM is valuated reasonably with a Price/Earnings ratio of 11.79.
  • Based on the Price/Earnings ratio, DORM is valued a bit cheaper than 68.29% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 24.88, DORM is valued rather cheaply.
  • DORM is valuated reasonably with a Price/Forward Earnings ratio of 11.68.
  • DORM's Price/Forward Earnings ratio is in line with the industry average.
  • DORM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 11.79
Fwd PE 11.68
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • DORM's Enterprise Value to EBITDA is on the same level as the industry average.
  • DORM's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 41.71
EV/EBITDA 8.75
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DORM does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of DORM may justify a higher PE ratio.
PEG (NY)12.46
PEG (5Y)0.57
EPS Next 2Y5.42%
EPS Next 3Y-0.14%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DORM Dividend Analysis

5.1 Amount

  • DORM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DORM Fundamentals: All Metrics, Ratios and Statistics

DORMAN PRODUCTS INC

NASDAQ:DORM (3/27/2026, 8:12:21 PM)

After market: 104.56 0 (0%)

104.56

-1.91 (-1.79%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-25
Earnings (Next)05-04
Inst Owners89.57%
Inst Owner Change0.85%
Ins Owners13.14%
Ins Owner Change2.74%
Market Cap3.16B
Revenue(TTM)2.13B
Net Income(TTM)204.19M
Analysts82.86
Price Target173.78 (66.2%)
Short Float %4.25%
Short Ratio4.96
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.11%
Min EPS beat(2)-0.69%
Max EPS beat(2)2.92%
EPS beat(4)3
Avg EPS beat(4)12.48%
Min EPS beat(4)-0.69%
Max EPS beat(4)36.11%
EPS beat(8)7
Avg EPS beat(8)22.38%
EPS beat(12)8
Avg EPS beat(12)10.5%
EPS beat(16)9
Avg EPS beat(16)7.26%
Revenue beat(2)0
Avg Revenue beat(2)-5.69%
Min Revenue beat(2)-8.11%
Max Revenue beat(2)-3.26%
Revenue beat(4)2
Avg Revenue beat(4)-1.28%
Min Revenue beat(4)-8.11%
Max Revenue beat(4)3.34%
Revenue beat(8)2
Avg Revenue beat(8)-1.64%
Revenue beat(12)2
Avg Revenue beat(12)-2.4%
Revenue beat(16)5
Avg Revenue beat(16)-0.69%
PT rev (1m)0%
PT rev (3m)-1.8%
EPS NQ rev (1m)-23.21%
EPS NQ rev (3m)-23.21%
EPS NY rev (1m)-7.47%
EPS NY rev (3m)-7.06%
Revenue NQ rev (1m)-1.65%
Revenue NQ rev (3m)-1.65%
Revenue NY rev (1m)0.56%
Revenue NY rev (3m)0.47%
Valuation
Industry RankSector Rank
PE 11.79
Fwd PE 11.68
P/S 1.48
P/FCF 41.71
P/OCF 27.77
P/B 2.14
P/tB 3.79
EV/EBITDA 8.75
EPS(TTM)8.87
EY8.48%
EPS(NY)8.95
Fwd EY8.56%
FCF(TTM)2.51
FCFY2.4%
OCF(TTM)3.77
OCFY3.6%
SpS70.59
BVpS48.94
TBVpS27.59
PEG (NY)12.46
PEG (5Y)0.57
Graham Number98.83
Profitability
Industry RankSector Rank
ROA 8.19%
ROE 13.82%
ROCE 17.81%
ROIC 13.2%
ROICexc 13.54%
ROICexgc 20.22%
OM 16.72%
PM (TTM) 9.59%
GM 42.14%
FCFM 3.55%
ROA(3y)7.22%
ROA(5y)6.94%
ROE(3y)13.19%
ROE(5y)13.07%
ROIC(3y)11.36%
ROIC(5y)10.19%
ROICexc(3y)11.65%
ROICexc(5y)10.5%
ROICexgc(3y)18.73%
ROICexgc(5y)16.69%
ROCE(3y)15.58%
ROCE(5y)14.81%
ROICexgc growth 3Y20.29%
ROICexgc growth 5Y5.06%
ROICexc growth 3Y25.64%
ROICexc growth 5Y0.33%
OM growth 3Y19.24%
OM growth 5Y6.5%
PM growth 3Y11%
PM growth 5Y-0.41%
GM growth 3Y8.98%
GM growth 5Y3.75%
F-Score8
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 5.81
Debt/EBITDA 0.98
Cap/Depr 68.13%
Cap/Sales 1.78%
Interest Coverage 13.02
Cash Conversion 27.58%
Profit Quality 37.06%
Current Ratio 3.09
Quick Ratio 1.14
Altman-Z 4.47
F-Score8
WACC9.45%
ROIC/WACC1.4
Cap/Depr(3y)72.66%
Cap/Depr(5y)71.81%
Cap/Sales(3y)2.01%
Cap/Sales(5y)1.94%
Profit Quality(3y)88.47%
Profit Quality(5y)65.95%
High Growth Momentum
Growth
EPS 1Y (TTM)24.23%
EPS 3Y23.06%
EPS 5Y20.72%
EPS Q2Q%-1.36%
EPS Next Y0.95%
EPS Next 2Y5.42%
EPS Next 3Y-0.14%
EPS Next 5Y6.46%
Revenue 1Y (TTM)6.03%
Revenue growth 3Y7.11%
Revenue growth 5Y14.28%
Sales Q2Q%0.78%
Revenue Next Year5.75%
Revenue Next 2Y5.33%
Revenue Next 3Y6%
Revenue Next 5Y5.64%
EBIT growth 1Y21.63%
EBIT growth 3Y27.72%
EBIT growth 5Y21.71%
EBIT Next Year14.35%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.51%
FCF growth 3Y171.04%
FCF growth 5Y-11.13%
OCF growth 1Y-50.82%
OCF growth 3Y39.68%
OCF growth 5Y-5.65%

DORMAN PRODUCTS INC / DORM Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DORMAN PRODUCTS INC (DORM) stock?

ChartMill assigns a fundamental rating of 6 / 10 to DORM.


Can you provide the valuation status for DORMAN PRODUCTS INC?

ChartMill assigns a valuation rating of 5 / 10 to DORMAN PRODUCTS INC (DORM). This can be considered as Fairly Valued.


What is the profitability of DORM stock?

DORMAN PRODUCTS INC (DORM) has a profitability rating of 9 / 10.


Can you provide the financial health for DORM stock?

The financial health rating of DORMAN PRODUCTS INC (DORM) is 7 / 10.


How sustainable is the dividend of DORMAN PRODUCTS INC (DORM) stock?

The dividend rating of DORMAN PRODUCTS INC (DORM) is 0 / 10 and the dividend payout ratio is 0%.